| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |